GlassScriptPhysician profile
Brent N Davidson
NPI 1336216480
$170,796.59
in general payments reported to CMS, 2019-2025
10 companies · $22K in 2025
The $22K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $30K · 2021: $25K · 2022: $21K · 2023: $24K · 2024: $22K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $55K · Travel and Lodging: $6,034 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,639 · Food and Beverage: $1,293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $55,094.93 |
| Travel and Lodging | $6,034.26 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,638.86 |
| Food and Beverage | $1,292.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gen-Probe, INC. | $60,913.91 | 2021-2025 | Aptima |
| Organon LLC | $31,977.24 | 2021-2024 | Nexplanon |
| Abbvie INC. | $25,370.51 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20,437.41 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $18,105.69 | 2019-2020 | |
| Hologic Sales and Service, LLC | $11,026.15 | 2019-2025 | Aptima, Fetal Fibronectin Enzyme Immunoassay, Btx |
| Duchesnay USA Incorporated | $1,931.21 | 2019 | |
| Gen-Probe Sales & Service, INC. | $434.47 | 2021 | |
| Covidien LP | $400.00 | 2019 | |
| Medtronic, INC. | $200.00 | 2021-2023 | Lapro-Clip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Davidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.